Becton Dickinson & Co
(NYSE:BDX)
$
221.9
-0.08 (-0.04%)
Market Cap: 64.16 Bil
Enterprise Value: 82.13 Bil
PE Ratio: 37.36
PB Ratio: 2.48
GF Score: 85/100 Becton Dickinson and Co at Evercore ISI HealthCONx Conference Transcript
Nov 28, 2023 / 01:20PM GMT
Release Date Price:
$237.28
(-0.66%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Great. Thanks, everyone, for joining us this morning. I'm Vijay Kumar, the med tech and life science tools analyst at Evercore. It's a pleasure to have with us Becton, Dickinson. Representing the company, we have Rick Byrd, EVP, President of BD Interventional and the CFO, Chris DelOrefice.
Chris and Rick, thank you both for joining us this morning.
Christopher J. DelOrefice
Becton, Dickinson and Company - Executive VP & CFO
Yes, thanks for having, good to be here.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Fantastic. So Chris, maybe I'm going to start off with you. When I look at your Q4 stock reaction, it's a pretty unusual reaction for BD. General view is BD is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot